{"transactions":[{"id":4114756,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-03T21:14:21.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":7439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":7439,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":7439},"source":{"system":"sec-edgar","filing":"0001237899-18-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789918000005/edgardoc.xml","form_type":"4"}},{"id":4196207,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-03T20:00:38.000Z","date":"2017-09-29","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":18.61,"expiration_date":"2019-01-02","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001237899-17-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000023/edgardoc.xml","form_type":"4"}},{"id":4196206,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T20:00:38.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":2000,"price":450,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001237899-17-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000023/edgardoc.xml","form_type":"4"}},{"id":4196205,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T20:00:38.000Z","date":"2017-09-29","kind":"exercise","acquired":true,"shares":2000,"price":18.61,"value":37220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001237899-17-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000023/edgardoc.xml","form_type":"4"}},{"id":4500100,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-05T21:05:09.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":7830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":7830,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":7830},"source":{"system":"sec-edgar","filing":"0001237899-17-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000010/edgardoc.xml","form_type":"4"}},{"id":4522712,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2000,"derivative":{"exercise_price":18.61,"expiration_date":"2019-01-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522711,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":200,"price":394.33,"value":78866.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on December 12, 2016 at prices ranging from $394.24 to $ 394.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522710,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":600,"price":393.64,"value":236184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 600 shares of Company stock on December 12, 2016 at prices ranging from $393.39 to $393.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price."}],"balance_after":9200,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522709,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":400,"price":392.41,"value":156964.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 400 shares of Company stock on December 12, 2016 at prices ranging from $392.00 to $392.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price."}],"balance_after":9800,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522708,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":1200,"price":391.36,"value":469632.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 1,200 shares of Company stock on December 12, 2016 at prices ranging from $391.02 to $391.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price."}],"balance_after":10200,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522707,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":600,"price":390.67,"value":234402.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 600 shares of Company stock on December 12, 2016 at prices ranging from $390.26 to $390.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price."}],"balance_after":11400,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}},{"id":4522706,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":170674,"kind":"person","name":"BAKER CHARLES A","position":1,"cik":"0001225470","reported_name":"BAKER CHARLES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-14T22:41:01.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":3000,"price":18.61,"value":55830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001237899-16-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000085/edgardoc.xml","form_type":"4"}}]}